Domainex in academic collaboration for asthma treatment
This article was originally published in Scrip
Executive Summary
The UK drug discovery company Domainex is to collaborate with two academic institutions in the UK – St George's, University of London and the University of Manchester – on a new programme to develop an improved treatment for asthma.